The effects of oral ibuprofen on medicinal closure of patent ductus arteriosus in full-term neonates in the second postnatalweek

Iranian Journal of Pediatrics

Volumn 26, Issue 4, 2016, Pages

  Alipour, Mohammad Reza ^a   Shamsi, Mansooreh Mozaffari ^a   Namayandeh, Seyedeh Mahdieh ^a   Pezeshkpour, Zohreh ^a   Rezaeipour, Fatemeh ^a   Sarebanhassanabadi, Mohammadtaghi ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Full term neonates; Oral ibuprofen; Patent ductus arteriosus

Indexed keywords

IBUPROFEN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART MURMUR; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 84988000476     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: 10.5812/ijp.5807     Document Type: Article

References (18)

1. Swartz EN. Is indomethacin or ibuprofen better for medical closure of the patent ductus arteriosus?. Arch Dis Child. 2003;88(12):1134-5. [PubMed: 14670792].
2. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr. 2002;161(4):202-7. [PubMed: 12014386].
3. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. Lippincott Williams and Wilkins; 2013.
4. AM R. The ductus arteriosus and persistent patency of the ductus arteriosus. 3 ed. UK: Futura Publishing House; 2001.
5. Alzamora-Castro V, Battilana G, Abugattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol. 1960;5:761-3. [PubMed: 13793062].
6. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003;112(5):e354. [PubMed: 14595076].
7. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thailand. 2002;85(4):S1252-8.
8. McIntyre JOB, van den Anker JN. Indomethacin Treatment of Patent Ductus Arteriosus in Premature Infants. Paediatr Perinat Drug Ther. 2001;4(3):85-91.
9. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971;43(3):323-32. [PubMed: 5102136].
10. Amoozgar H, Ghodstehrani M, Pishva N. Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study. Pediatr Cardiol. 2010;31(1):40-3. doi: 10.1007/s00246-009-9542-y. [PubMed: 19841966].
11. Jones RW, Pickering D. Persistent ductus arteriosus complicating the respiratory distress syndrome. Arch Dis Child. 1977;52(4):274-81. [PubMed: 324406].
12. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996;224(3):350-5. [PubMed: 8813263] discussion 355-7.
13. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr. 2005;164(3):135-40. doi: 10.1007/s00431-004-1596-5. [PubMed: 15717178].
14. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed. 1997;76(3):F179-84. [PubMed: 9175948].
15. Jameii Khosroshahi A, Kianfar A, Mohammadpour Aharanjani B, Sayadpour Zanjani K. Usefulness of serum brain natriuretic Peptide level for screening hemodynamically significant patent ductus arteriosus in preterm neonates. Iran J Pediatr. 2014;24(6):766-9. [PubMed: 26019784].
16. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135(5 Pt 1):825-32. [PubMed: 9588412].
17. Pistulli E, Hamiti A, Buba S, Hoxha A, Kelmendi N, Vyshka G. The Association between Patent Ductus Arteriosus and Perinatal Infection in A Group of Low Birth Weight Preterm Infants. Iran J Pediatr. 2014;24(1):42-8. [PubMed: 25793044].
18. Pourarian S, Rezaie M, Amoozgar H, Shakiba AM, Edraki MR, Mehdizadegan N. High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates. Iran J Pediatr. 2015;25(4):e2005. doi: 10.5812/ijp.2005. [PubMed: 26396694].